1. Articles in category: Other Business News

    1057-1080 of 1190 « 1 2 ... 42 43 44 45 46 47 48 49 50 »
    1. Datasheet: SU-LDH Digital Line Scan Camera

      The new SU-LDH-1.7 Linear Digital High speed InGaAs Camera increases line rates for 1024 pixels to over 46,000 lines per second for spectral-domain optical coherence tomography (SD-OCT), NIR spectroscopy and machine vision. This versatile high speed camera provides 14-bit digital capture into base format Camera Link® interface cards. It utilizes the new LC series of linear arrays, which feature double-sampling, integrate-whileread acquisition and low noise, delivering the high dynamic range demanded by these applications. The camera is available with 500 µm tall pixels for easy alignment in SD-OCT systems, or square 25 µm pixels for high-time resolution machine ...
      Read Full Article
    2. Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager

      Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager
      Orpington, UK, June 23rd, 2009: Michelson Diagnostics Limited (MDL) announced today that it has opened a sales and support office in the USA. The office is located in Fuquay-Varina, (in the Research Triangle vicinity of Raleigh-Durham), North Carolina, and is headed by Kevin C. Oakley, Business Development Manager (US) for Michelson Diagnostics. The new office will act as a hub for growth of MDL’s business in the field of Optical Coherence Tomography (OCT) imaging, which has great applications potential in fields such as skin cancer diagnosis, genetics research and tissue engineering development. The company has no FDA-approved clinical products ...
      Read Full Article
    3. U.S. Optical Imaging Technologies to Benefit from Technical Advances and Rising Uptake in Certain Application Areas Says Frost & Sullivan

      The use of optical technologies in clinics is currently limited due to restricted availability of validated data and low end-user awareness. However, technological advances, along with manufacturers' emphasis on promoting end-user education, are likely to result in some optical technologies, such as optical coherence tomography (OCT) and fluorescence spectroscopy, gaining market presence in certain applications such as ophthalmology, dentistry, and cancer screening over the next five to ten years.
      Read Full Article
      Mentions: Madhu Sharma
    4. Imalux Corp. hires new president, CEO: Michael Burke

      Imalux Corp. hires new president, CEO: Michael Burke
      CLEVELAND, Ohio — Medical imaging technology company Imalux Corp. has named a new president and chief executive: Michael Burke. Burke, a veteran health care industry entrepreneur, left TREK Diagnostic Systems in Independence, Ohio, as its founding chief executive in November after selling the company to Magellan Biosciences in late 2006. “We are very pleased to have Mike assume the leadership role at Imalux,” said Bill Sanford, the company’s chairman, in a written statement. “He has a track record of success in all phases of commercialization of medical technologies on a worldwide basis.”
      Read Full Article
    5. Oclaro New Focus Photoreceiver Enables Cancer Detection Breakthrough

      N JOSE, Calif., June 2 /-- Oclaro, Inc. (NASDAQ: OCLR), has announced that its New Focus(TM) 2117 photoreceivers are underpinning an award winning breakthrough cancer detection system developed by scientists from Japan's Kitasato University. This unique optical demultiplexed (OD) optical coherence tomography (OCT) medical imaging system, received the 'Customer Application of the Year' Award from National Instruments. It delivers faster, more accurate tissue analysis with minimal stress on the patient when compared to existing techniques. The OD-OCT system incorporates 256 custom-designed New Focus 2117 photoreceivers enabling the high-speed gathering and interpretation of data, with the optical demultiplexers simultaneously collecting ...
      Read Full Article
    6. West Coast-based Volcano opens East Coast HQ in Billerica

      West Coast-based Volcano opens East Coast HQ in Billerica
      San Diego-based medical software and imaging systems maker Volcano Corp. sees the Bay State as a promising place to do business and will be expanding its research and manufacturing footprint in Massachusetts, as it makes the Bay State its East Coast headquarters. In December, Volcano bought out 90-strong Axsun Inc. of Billerica for $21.5 million. Privately held Axsun primarily made systems to monitor signal quality for the telecommunications industry. However, its portfolio also included medical lasers and optical engines that relied on optical coherence tomography.
      Read Full Article
    7. Carl Zeiss Meditec Receives FDA Clearance for Cirrus HD-OCT Software Version 4.0

      DUBLIN, Calif.--(BUSINESS WIRE)--A new suite of optical coherence tomography (OCT) software applications for the Cirrus™ HD-OCT has been cleared by the U.S. Food and Drug Administration (FDA) for commercial distribution. The Cirrus HD-OCT 4.0 with Retinal Nerve Fiber Layer and Macular Normative Databases is indicated for in-vivo viewing, axial cross-sectional, and three-dimensional imaging and measurement of anterior and posterior ocular structures. “Throughout our 15 year history of OCT innovation, we have seen its utility evolve from imaging of the retina to now offering both posterior and anterior capabilities,” said Michael Kaschke, PhD, President and Chief Executive ...
      Read Full Article
    8. Research and Markets: Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets

      Dublin, Jun 04, 2009 (M2 PRESSWIRE via COMTEX) -- FRSU | Quote | Chart | News | PowerRating -- Research and Markets (http://www.researchandmarkets.com/research/847378/strategic_analysis) has announced the addition of Frost & Sullivan's new report "Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics and Drug Discovery Markets" to their offering. This research service analyzes optical technologies within the United States clinical imaging and drug discovery markets. The market is further divided into seven distinct sub-segments. Each segment covers key challenges, market trends, technology trends, competitive structure and revenue forecasts, with a base year of 2007.
      Read Full Article
    9. TR Design Directs Corporate Branding Efforts with LightLab Imaging Inc., Leader in Medical Device Market

      ANDOVER, Mass.--(BUSINESS WIRE)--TR Design, a leading strategic design firm that focuses on the medical device market, recently announced that it is working with LightLab Imaging Inc. of Westford, MA to revitalize and implement the company’s corporate brand. LightLab Imaging is a pioneer in the development of Optical Coherence Tomography, a high-resolution imaging modality that applies advanced photonics to medical imaging. TR Design is responsible for directing LightLab Imaging through the brand development and product messaging processes, in addition to managing and implementing the materials that help bring the brand to life. “LightLab's needs are a perfect ...
      Read Full Article
    10. vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque

      Six-Month Follow-Up Shows Reduced Stenosis, Healthy Endothelial Regrowth in Vessel Treated Proactively for Vulnerable Plaque DOYLESTOWN, Pa., June 1 /PRNewswire/ -- Six months after placement of a vProtect(TM) Luminal Shield to treat a "vulnerable" plaque, a follow-up exam revealed reduced plaque burden and reduced stenosis in the target vessel. The exam was part of the SECRITT I trial, a randomized study designed to evaluate the vProtect(
      Read Full Article
    11. Intravascular Ultrasound (IVUS) Market: An Analysis -- IVUS market is the fastest growing segment of interventional cardiology

      The report analyzes the IVUS market looking at the market from global as well as regional perspective. The various market related factors are being interpreted either as market drivers or market limiters. IVUS market is the fastest growing segment of interventional cardiology. IVUS is primarily used during the stenting procedure in the percutaneous coronary intervention (PCI). The growth in this market is mainly based on the number of PCI procedures and stenting procedures or the stenting placements. More the stents being used, more would be the need of IVUS technology.
      Read Full Article
    12. Market Scope Expects Retina Pharmaceutical Industry to Top $3.5 Billion by 2014

      Advances in diagnostic equipment have laid the groundwork for better diagnosis and monitoring of retinal disease. This is most evident in the new optical coherence technology (OCT) devices that have dramatically improved image resolution and provided real-time cross-sectional images of retinal tissues. Carl Zeiss, Heidelberg, Topcon and Optovue are currently the lead competitors in the rapidly expanding OCT market. Despite tight capital budgets, Market Scope expects growing demand for retinal care and new diagnostic technologies to result in a compounded annual growth of 6.4 percent in the retinal diagnostic equipment segment over the next five years.
      Read Full Article
    13. Optical Coherence Tomography (OCT) Presentations by Volcano at EuroPCR 2009

      Optical Coherence Tomography (OCT) Presentations by Volcano at EuroPCR 2009
      May 19, 2009 -- San Diego and Barcelona -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, today highlights its technology leadership position in the emerging field of Optical Coherence Tomography (OCT) at the EuroPCR conference in Barcelona, Spain.
      Read Full Article
    14. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents

      Angiographic and optical coherence tomography (OCT) imagery were reviewed illustrating the new stent platform's deliverability, design features, and vessel scaffolding. "The nature of the polymeric materials allows for tremendous innovation in stent ...
      Read Full Article
    15. Volcano Announces OCT Activities at EuroPCR 2009

      Volcano's Axsun Laser - At the Heart of OCT SAN DIEGO and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral artery disease, today highlights its technology leadership position in the emerging field of Optical Coherence Tomography (OCT) at the EuroPCR conference in Barcelona, Spain. Volcano's wholly owne
      Read Full Article
    16. Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter

      SAN DIEGO, May 18 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced an exclusive worldwide distribution agreement to initiate the formal launch of the Xtract(TM) thrombus aspiration catheter, manufactured by Lumen Biomedical. The Xtract(TM) thrombus aspiration catheter is available for immediate sale in the U.S. and Europe. This marks Volcano's entry into what we believe is a $70+ million aspiration market.
      Read Full Article
    17. Volcano Corporation Presentation at JMP Conference to be Webcast

      SAN DIEGO, May 12, 2009 - Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Eighth Annual JMP Securities Research Conference on Monday, May 18.
      Read Full Article
    18. Volcano Corp Q1 2009 Earnings Call Transcript

      As we reported in 10-K for 2008, the Superior Court in Massachusetts in January issued a preliminary adjunction against Axsun and Volcano in response to a complaints filled by LightLab, a wholly owned subsidiary of Goodman. The initial injunction prohibited Volcano from using Axsun tunable lasers and Volcano's OCT products under development, but ordered a full hearing following a more complete discovery. We are pleased to report that as a results of the full hearing that occurred in March, the trial court reconsider the broad injunction and issued a much more limited order to provide simply that a) Axsun ...
      Read Full Article
    1057-1080 of 1190 « 1 2 ... 42 43 44 45 46 47 48 49 50 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. OCT Companies in the News

    1. (2 articles) PhotoniCare
    2. (1 articles) Cylite
    3. (1 articles) Canon Medical Systems
    4. (1 articles) Carl Zeiss Meditec
    5. (1 articles) Perimeter Medical Imaging